Dean Capital Management’s Quest Diagnostics Inc Position
Does Dean Capital Management own Quest Diagnostics Inc (DGX)? Yes — 12.5K shares worth $2M (+1.01% of its 13F portfolio) as of Q1 2026, down from 12.5K shares the prior filed quarter.
Position Value
$2M
Q1 2026
Shares
12.5K
% of Portfolio
+1.01%
Quarters Held
17
currently held
Position History DGX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 12.5K | $2M | +1.01% |
| Q4 2025 | 12.5K | $2M | +0.92% |
| Q3 2025 | 12.1K | $2M | +0.90% |
| Q2 2025 | 12.1K | $2M | +0.89% |
| Q1 2025 | 11.4K | $2M | +0.84% |
| Q4 2024 | 11.2K | $2M | +0.72% |
| Q3 2024 | 11.0K | $2M | +0.73% |
| Q1 2024 | 11.0K | $1M | +0.86% |
| Q4 2023 | 11.0K | $2M | +0.94% |
| Q3 2023 | 6.9K | $840,712 | +0.63% |
| Q4 2020 | 5.9K | $700,000 | +0.42% |
| Q3 2020 | 6.2K | $714,000 | +0.74% |
| Q2 2020 | 6.1K | $699,000 | +0.82% |
| Q1 2020 | 5.5K | $439,000 | +0.65% |
| Q4 2019 | 5.8K | $621,000 | +0.59% |
| Q3 2019 | 5.7K | $614,000 | +0.63% |
| Q2 2019 | 6.0K | $609,000 | +0.63% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dean Capital Management’s full portfolio or all institutional holders of DGX.